FFCP PHASE1:Mm9::chr11:109477438..109477465,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=|HGNC=|MCL_coexpression_id=3|UniProt=|association_with_transcript=-168bp_to_ENSMUST00000141559_5end|description=CAGE_peak_1_at_ENSMUST00000141559_5end|id=chr11:109477438..109477465,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=CL:0000355,1.41e-11,9|ontology_enrichment_disease=DOID:0060100!8.53e-15!3;DOID:4045!8.53e-15!3;DOID:0050686!1.24e-07!6|ontology_enrichment_disease_v019_2=DOID:0060100,3.61e-33,3;DOID:4045,3.61e-33,3;DOID:0050686,5.29e-17,6|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.41e-11,9;UBERON:0002036,1.41e-11,9;UBERON:0002385,1.41e-11,9;UBERON:0000486,1.41e-11,9;UBERON:0007503,1.41e-11,9;UBERON:0001015,1.41e-11,9;UBERON:0002329,1.41e-11,9;UBERON:0003082,1.41e-11,9;UBERON:0003059,1.41e-11,9;UBERON:0007282,1.41e-11,9;UBERON:0004290,1.41e-11,9;UBERON:0009618,1.41e-11,9;UBERON:0000383,1.74e-10,10;UBERON:0007524,1.36e-09,11;UBERON:0003077,1.36e-09,11;UBERON:0007285,1.36e-09,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.62622750694888,10.1573594788094,7.32933241563318,12.9410927366823,13.6609096991689,13.5942898848723,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.76922110389975,0,0,0.484875253135222,0,0,0,0,0,0,0.127070227073065,0,0,0,0,0,0,0,0,0.248813941220186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.154267112887378,0.232533944750408,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202860121388503,0,0.25462585178142,0,0,0,1.43768206527355,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.491764273019036,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.183151624267265,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.147198920134397,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.220591419119515,0|short_description=p1@ENSMUST00000141559}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene= | |||
|HGNC= | |||
|MCL_coexpression_id=3 | |||
|TSSclassifier=NA | |||
|UniProt= | |||
|association_with_transcript=-168bp_to_ENSMUST00000141559_5end | |||
|cluster_id=chr11:109477438..109477465,+ | |||
|description=CAGE_peak_1_at_ENSMUST00000141559_5end | |||
|id=chr11:109477438..109477465,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,1.41e-11,9 | |||
|ontology_enrichment_disease=DOID:0060100!8.53e-15!3;DOID:4045!8.53e-15!3;DOID:0050686!1.24e-07!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,3.61e-33,3;DOID:4045,3.61e-33,3;DOID:0050686,5.29e-17,6 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.41e-11,9;UBERON:0002036,1.41e-11,9;UBERON:0002385,1.41e-11,9;UBERON:0000486,1.41e-11,9;UBERON:0007503,1.41e-11,9;UBERON:0001015,1.41e-11,9;UBERON:0002329,1.41e-11,9;UBERON:0003082,1.41e-11,9;UBERON:0003059,1.41e-11,9;UBERON:0007282,1.41e-11,9;UBERON:0004290,1.41e-11,9;UBERON:0009618,1.41e-11,9;UBERON:0000383,1.74e-10,10;UBERON:0007524,1.36e-09,11;UBERON:0003077,1.36e-09,11;UBERON:0007285,1.36e-09,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,9.62622750694888,10.1573594788094,7.32933241563318,12.9410927366823,13.6609096991689,13.5942898848723,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.76922110389975,0,0,0.484875253135222,0,0,0,0,0,0,0.127070227073065,0,0,0,0,0,0,0,0,0.248813941220186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.154267112887378,0.232533944750408,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202860121388503,0,0.25462585178142,0,0,0,1.43768206527355,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.491764273019036,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.183151624267265,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.147198920134397,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.220591419119515,0 | |||
|short_description=p1@ENSMUST00000141559 | |||
}} |
Latest revision as of 09:13, 5 August 2015
Short description: | p1@ENSMUST00000141559 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_1_at_ENSMUST00000141559_5end |
Coexpression cluster: | MCL_coexpression_mm9:3 |
Association with transcript: | -168bp_to_ENSMUST00000141559_5end |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 1.41e-11 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 1.41e-11 | 9 |
striated muscle tissue | 1.41e-11 | 9 |
muscle tissue | 1.41e-11 | 9 |
multilaminar epithelium | 1.41e-11 | 9 |
epithelial vesicle | 1.41e-11 | 9 |
musculature | 1.41e-11 | 9 |
somite | 1.41e-11 | 9 |
myotome | 1.41e-11 | 9 |
presomitic mesoderm | 1.41e-11 | 9 |
presumptive segmental plate | 1.41e-11 | 9 |
dermomyotome | 1.41e-11 | 9 |
trunk paraxial mesoderm | 1.41e-11 | 9 |
musculature of body | 1.74e-10 | 10 |
dense mesenchyme tissue | 1.36e-09 | 11 |
paraxial mesoderm | 1.36e-09 | 11 |
presumptive paraxial mesoderm | 1.36e-09 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 3.61e-33 | 3 |
muscle cancer | 3.61e-33 | 3 |
organ system cancer | 5.29e-17 | 6 |